Sign in

    Hims & Hers Health Inc (HIMS)

    You might also like

    Hims & Hers Health, Inc. is a consumer-first health and wellness platform that leverages technology to provide accessible and affordable healthcare solutions. The company offers a wide range of prescription and non-prescription products, telehealth services, and wellness content through its websites, mobile applications, and retail partnerships. Its offerings focus on addressing common health conditions, promoting lifelong wellness, and simplifying the healthcare experience for customers.

    1. Online Revenue - Provides prescription and non-prescription products directly to individual customers through the company's websites and mobile applications. Includes telehealth consultations with licensed healthcare professionals who can prescribe medications when appropriate, fulfilled via licensed pharmacies.

      • Prescription Products - Addresses conditions such as sexual health, hair loss, dermatology, mental health, weight loss, and primary care.
      • Non-Prescription Products - Includes over-the-counter drugs, cosmetics, supplements, and wellness items such as melatonin, biotin, skincare products, sexual health products, and hair care solutions.
    2. Wholesale Revenue - Sells products to wholesale partners and third-party platforms, making Hims & Hers products available in tens of thousands of retail locations across the United States.

    1. Given the recent gross margin degradation driven by the scaling of your weight loss specialty, particularly GLP-1 offerings, how do you plan to offset these margin pressures going forward, and what are your expectations for gross margins as this segment continues to grow?
    2. With the evolving regulatory landscape around compounded GLP-1 medications and potential shortages of name-brand options, how do you anticipate these factors impacting your weight loss specialty, and what steps are you taking to mitigate associated risks?
    3. You mentioned significant investments in both 503(a) and 503(b) facilities to support personalized weight loss solutions; can you elaborate on how these investments align with your capital allocation priorities and their expected impact on operational efficiency?
    4. Considering that higher-priced weight loss solutions contribute to the increased average revenue per subscriber, how sustainable is this growth, and what strategies are you implementing to ensure long-term retention and diversification across other specialties?
    5. As you broaden your personalized and multi-specialty offerings, what challenges do you foresee in maintaining high retention rates and customer satisfaction, especially with the integration of new treatments like GLP-1s, and how do you plan to address them?
    Program DetailsProgram 1Program 2
    Approval DateOctober 26, 2023 July 24, 2024
    End Date/DurationFully utilized by Sept 30, 2024 Expires August 31, 2027
    Total Additional Amount$50.0 million $100.0 million
    Remaining Authorization$0.0 million $70.0 million
    DetailsFully utilized to repurchase 3,632,123 shares of Class A common stock for $48.0 million $30.0 million spent to repurchase 1,897,183 shares of Class A common stock